Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Headlam Group (HEAD) by Steve Moore in ShareProphets
- Buy easyJet (EZJ) by UBS
- Speculative Buy Gulf Keystone Petroleum Ltd Com Shs (DI) (GKP) by Canaccord Genuity
- Buy Hochschild Mining (HOC) by Canaccord Genuity
- Buy Kier Group (KIE) by Berenberg
- Buy Iofina (IOF) by Canaccord Genuity
- Buy Premier Foods (PFD) by Berenberg
- Buy Serica Energy (SQZ) by Canaccord Genuity
- Buy Team17 Group (TM17) by Shore Capital
- Hold BHP Group Limited NPV (DI) (BHP) by Berenberg
- Buy Taseko Mines Limited NPV (DI) (TKO) by Canaccord Genuity
- Buy Kooth (KOO) by Canaccord Genuity
- Buy PensionBee Group (PBEE) by Canaccord Genuity
- Buy Afentra (AET) by Canaccord Genuity
- Buy Associated British Foods (ABF) by Shore Capital
- Buy Spectris (SXS) by Shore Capital
- Buy Capricorn Energy (CNE) by Shore Capital
- Hold CMC Markets (CMCX) by Shore Capital
- Avoid The Revel Collective (TRC) by Steve Moore in ShareProphets
- Buy Hochschild Mining (HOC) by Bank of America
Avacta Group (AVCT) Share Price
Health Care Sector
NOTE: This is based on 61 open tips for Avacta Group (AVCT)
| Latest Bid : 46.00p | Latest Ask : 47.00p |
| High Today : 48.80p | Low Today : 46.24p |
| This Years High : 108.50p | This Years Low : 39.75p |
| Volume : 720,155 | MKT Cap : £171.59M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000
Avacta Group (AVCT) Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.Avacta Group (AVCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Lucian Miers | Premium Only | 2024-12-27 10:05:00 27/12/2024 | 3.13% |
| Sell | Tom Winnifrith | Premium Only | 2024-12-12 13:30:00 12/12/2024 | -8.14% |
| Hold | Deutsche Bank | Premium Only | 2024-12-10 07:30:00 10/12/2024 | 2.76% |
| Sell | Tom Winnifrith | Premium Only | 2024-09-17 10:35:00 17/09/2024 | 18.42% |
| Sell | Deutsche Bank | Premium Only | 2024-09-17 07:27:00 17/09/2024 | 33.46% |
Avacta Group (AVCT) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| GSA Capital Partners LLP | 0.78% | 10/07/2024 |
| Latest Bid : 46.00p | Latest Ask : 47.00p |
| High Today : 48.80p | Low Today : 46.24p |
| This Years High : 108.50p | This Years Low : 39.75p |
| Volume : 720,155 | MKT Cap : £171.59M |
Avacta Group Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Avacta Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Lucian Miers | Premium Only | 2024-12-27 10:05:00 27/12/2024 | 3.13% |
| Sell | Tom Winnifrith | Premium Only | 2024-12-12 13:30:00 12/12/2024 | -8.14% |
| Hold | Deutsche Bank | Premium Only | 2024-12-10 07:30:00 10/12/2024 | 2.76% |
| Sell | Tom Winnifrith | Premium Only | 2024-09-17 10:35:00 17/09/2024 | 18.42% |
| Sell | Deutsche Bank | Premium Only | 2024-09-17 07:27:00 17/09/2024 | 33.46% |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000